ERCP术后联合熊去氧胆酸治疗梗阻性黄疸的疗效观察
摘要
关键词
全文:
PDF参考
[1]Moy B T,Dojki F K,Scholes J V,et al.Azithromycin-induced cholestatic hepatitis[J].Conn Med,2015,79(4):213-215. [2]杨柳,张金坤.内镜下逆行胰胆管造影术治疗胰腺癌导致的梗阻性黄疸的临床疗效[J].实用临床医学,2019,20(5):14-16,19. [3]Dalpiaz A, Paganetto G, Pavan B, et al. Zidovudine and ursodeoxycholic acid conjugation: design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system[J].Mol Pharm,2012,9(4):957-968. [4]张成龙,李春生,余晓兰.熊胆有效成分熊去氧胆酸中国专利进展[J].中国中药杂志,2012,37(19):2851-2854. [5]中华医学会消化内镜分会ERCP学组.ERCP诊治指南(2010版)[J].中华消化内镜杂志,2010,27(3):113-228. [6]王文君,于聪慧,杨荣华,等.恶性梗阻性黄疸手术治疗研究进展[J].现代生物医学进展,2016,16(14):2797-2800. [7]李敏利,吕莉慧,金鑫鑫,等.内镜下逆行胰胆管造影术在老年患者不同类型梗阻性黄疸中的应用价值[J].胃肠病学和肝病学杂志,2017,26(3):335-337. [8]Voaklander R, Kim E, Brown W H, et al. An overview of the evolution of direct cholangioscopy techniques for diagnosis and therapy[J].Gastroenterol Hepatol(N Y),2016,12(7):433-437. [9]张小坚,张联合,张士良,等.经内镜逆行胰胆管造影术与经皮肝穿刺胆道引流术治疗恶性梗阻性黄疸的比较[J].中华全科医学,2016,14(4):575-577. [10]李磊,李冰,丁惠国.熊去氧胆酸对不同原因胆汁淤积性肝病患者鼻胆管引流术后胆汁排泌的影响[J].临床肝胆病杂志,2016,32(3):522-525. [11]Tang ruqi, Weiyiran, Li yanmei, et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy[J].Gut,2018,67(3):534-541. [12]尹东亮,尹润龙,卢沛林,等.熊去氧胆酸对腹腔镜胆总管结石取石术后结石再发的预防及肝功能恢复的影响[J].中国现代药物应用,2019,13(11):90-92. [13]李立新,韩喜春,刘松平.熊去氧胆酸对胆总管结石合并肝生化异常患者ERCP术后肝功能的影响[J].肝脏,2019,24(7):798-800. [14]蒋孙路,黄强,翟东升.经内镜逆行胰胆管造影术和经皮穿刺胆道引流术治疗恶性梗阻性黄疸的疗效对比[J].中国内镜杂志,2018,24(1):75-79. 研究组黄疸缓解率为95.00%略高于对照组的91.25%， [15]沈浩,丁浩,杜芳腾.176例梗阻性黄疸病因及诊治分析[J].实用临床医学,2016,17(11):1-4.
(117 摘要 Views, 187 PDF Downloads)
Refbacks
- 当前没有refback。